New hope for endometriosis pain: phase 3 trial underway
NCT ID NCT07015268
First seen Mar 04, 2026 · Last updated Jun 18, 2026 · Updated 12 times
Summary
This Phase 3 study tests whether a new drug, KLH-2109, works as well as an existing treatment (leuprorelin) for reducing pelvic pain in endometriosis. About 288 premenopausal women with confirmed endometriosis will take part. The main goal is to see if KLH-2109 can lower daily pain scores over 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Multiple Locations, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.